Intravenous immunoglobulin and intravenous methylprednisolone as optimal induction treatment in chronic inflammatory demyelinating polyradiculoneuropathy: protocol of an international, randomised, double-blind, placebo-controlled trial (OPTIC)

BACKGROUND: International guidelines recommend either intravenous immunoglobulin (IVIg) or corticosteroids as first-line treatment for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). IVIg treatment usually leads to rapid improvement and is generally safe, but does not seem to lead...

Descripción completa

Detalles Bibliográficos
Autores principales: Bus, S. R. M., Zambreanu, L., Abbas, A., Rajabally, Y. A., Hadden, R. D. M., de Haan, R. J., de Borgie, C. A. J. M., Lunn, M. P., van Schaik, I. N., Eftimov, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894234/
https://www.ncbi.nlm.nih.gov/pubmed/33608058
http://dx.doi.org/10.1186/s13063-021-05083-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894234/
https://www.ncbi.nlm.nih.gov/pubmed/33608058
http://dx.doi.org/10.1186/s13063-021-05083-1

Ejemplares similares